SAFETY-A + CLASP for Youth Suicide Prevention
(YPIC-SP Trial)
Trial Summary
What is the purpose of this trial?
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment SAFETY-A + CLASP for Youth Suicide Prevention?
Is the SAFETY-A + CLASP treatment generally safe for humans?
The research highlights the importance of using multiple methods to detect adverse events (unwanted effects from treatment) in suicide prevention studies, suggesting that careful monitoring is crucial. However, there is no specific safety data available for the SAFETY-A + CLASP treatment itself.678910
How is the SAFETY-A + CLASP treatment for youth suicide prevention different from other treatments?
Research Team
Joan R Asarnow, PhD
Principal Investigator
University of California, Los Angeles
David Goldston, PhD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for young people aged 15-24 who have recently experienced suicidal thoughts or behaviors. They must be able to give informed consent and engage in the study, which means they can't have conditions like active psychosis or drug dependence that would interfere. Participants and their parents must speak English fluently, with parents also having the option of Spanish.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive SAFETY-A integrated within usual ED Care, with or without additional therapeutic follow-up contacts using the CLASP model
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3, 6, and 12 months
Treatment Details
Interventions
- Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
- SAFETY-A within usual ED Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Duke University
Collaborator
Brown University
Collaborator
Olive View-UCLA Education & Research Institute
Collaborator
RAND
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
University of Utah
Collaborator